Table 2.
Characteristics of liver transplant recipients with HCC from a validation cohort
| Parameters | With recurrence (n=49) | Without recurrence (106) | P |
|---|---|---|---|
| Age | 53.02±8.05 | 54.42±8.24 | 0.322 |
| Sex (male) | 45 | 99 | 0.988 |
| Maintenance | 0.355 | ||
| Tacrolimus | 38 | 89 | |
| Cyclosporin A | 11 | 17 | |
| Tumor-free survival (months) | 16.69±9.47 | 28.32±14.58 | 0.000 |
| Status (alive) | 18 | 102 | 0.000 |
| Cum survival (months) | 26.33±13.20 | 28.32±14.58 | 0.416 |